Thailand, Korea team up for nanoparticle drug delivery research; Nanoparticles have emerged as potential delivery vector;

>  Thailand and Korea have signed a memorandum of understanding to cooperate in research on nanoparticles for anti-cancer drug delivery. More here

> Nanoparticles have emerged as a potential vector for delivery of therapeutic or contrast agents to brain tumors. Abstract

> Baxter's Kristie Zinselmeier and BD's Brian Lynch will present a joint discussion on enhanced delivery options for injectables on April 20. Sign-up

> Controlled Delivery Systems: From Pharmaceuticals to Cells and Genes. Abstract

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.